Hemophagocytic lymphohistiocytosis causes: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{HPL}} {{CMG}} ==Overview== ==Causes== Familial hemophagocytic lymphohistiocytosis is inherited in an autosomal recessive pattern, which means both copies o...")
 
Line 6: Line 6:
Familial hemophagocytic lymphohistiocytosis is [[inherited]] in an [[autosomal recessive]] pattern, which means both copies of the gene in each cell have mutations.  The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.  
Familial hemophagocytic lymphohistiocytosis is [[inherited]] in an [[autosomal recessive]] pattern, which means both copies of the gene in each cell have mutations.  The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.  


Five genetic subtypes of the familial form of the disease (FHL1, FHL2, FHL3, FHL4, and FHL5) are described.   
Five genetic subtypes of the [[familial]] form of the disease (FHL1, FHL2, FHL3, FHL4, and FHL5) are described.   


The five subtypes of FHL are each associated with a specific gene:
The five subtypes of FHL are each associated with a specific gene:
* FHL1 - HPLH1
* FHL1 - HPLH1
* FHL2 - PRF1 (Perforin)
* FHL2 - PRF1 ([[Perforin]])
* FHL3 - UNC13D (Munc13-4)
* FHL3 - UNC13D (Munc13-4)
* FHL4 - STX11 (Syntaxin 11)
* FHL4 - STX11 ([[Syntaxin]] 11)
* FHL5 – STXBP2 (Syntaxin binding protein 2)/UNC18-2
* FHL5 – STXBP2 ([[Syntaxin binding protein]] 2)/UNC18-2


Molecular genetic testing for four of the causative genes, PRF1 (FHL2), UNC13D (FHL3), STX11 (FHL4), and STXBP2 (FHL5), is available on a clinical basis.
Molecular genetic testing for four of the causative genes, PRF1 (FHL2), UNC13D (FHL3), STX11 (FHL4), and STXBP2 (FHL5), is available on a clinical basis.
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 13:47, 21 September 2012

Hemophagocytic lymphohistiocytosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophagocytic lymphohistiocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophagocytic lymphohistiocytosis causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophagocytic lymphohistiocytosis causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophagocytic lymphohistiocytosis causes

CDC on Hemophagocytic lymphohistiocytosis causes

Hemophagocytic lymphohistiocytosis causes in the news

Blogs on Hemophagocytic lymphohistiocytosis causes

Directions to Hospitals Treating Hemophagocytic lymphohistiocytosis

Risk calculators and risk factors for Hemophagocytic lymphohistiocytosis causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Causes

Familial hemophagocytic lymphohistiocytosis is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Five genetic subtypes of the familial form of the disease (FHL1, FHL2, FHL3, FHL4, and FHL5) are described.

The five subtypes of FHL are each associated with a specific gene:

Molecular genetic testing for four of the causative genes, PRF1 (FHL2), UNC13D (FHL3), STX11 (FHL4), and STXBP2 (FHL5), is available on a clinical basis.

References

Template:WH Template:WS